Kineto Forte Tablet contains Serratiopeptidase 15 mg, a proteolytic enzyme widely used for its anti-inflammatory, analgesic, and fibrinolytic properties. Serratiopeptidase facilitates the breakdown of abnormal or excessive proteins at sites of inflammation, thereby reducing swelling, pain, and promoting faster healing. It is commonly prescribed as an adjunct therapy in conditions such as postoperative inflammation, traumatic injuries, musculoskeletal disorders, and chronic inflammatory diseases. By enhancing the clearance of inflammatory mediators and fibrin deposits, Kineto Forte aids in improving tissue repair and reducing stiffness and discomfort associated with inflammatory processes. The enzyme also supports the resolution of edema and facilitates improved blood flow in affected areas. Kineto Forte is typically administered orally, with dosage and duration tailored according to the severity of the condition and patient response. It is generally well-tolerated, with minimal adverse effects; however, caution is advised in patients with bleeding disorders or those on anticoagulant therapy due to the potential risk of increased bleeding. Kineto Forte should be used under medical supervision, ensuring appropriate monitoring and adjustment to optimize therapeutic outcomes while minimizing risks.